PATIENT SELF-ASSESSMENTS IN ADVANCED PARKINSON'S DISEASE WITHIN UPDRS AND "OFF" TIME SUBGROUPS: COMPARISON OF IPX066 WITH IMEDIATE-RELEASE CARBIDOPA-LEVODOPA

被引：0

作者：

Rubens, R. ^{[1
]}

Rustay, N. R. ^{[1
]}

Khanna, S. ^{[1
]}

Kell, S. ^{[1
]}

Gupta, S. ^{[1
]}

机构：

[1] Impax Labs Inc, Hayward, CA USA

来源：

VALUE IN HEALTH | 2015年 / 18卷 / 03期

关键词：

D O I：

10.1016/j.jval.2015.03.1628

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

PND8

引用

页码：A279 / A279

页数：1

共 46 条

[41] Efficacy and safety of IPX066, a new carbidopa-levodopa (CD-LD) extended-release formulation, in LD-naive early Parkinson's disease (APEX-PD trial)
Pahwa, R.
Ellenbogen, A.
Jankovic, J.
Hauser, R.
Fahn, S.
MOVEMENT DISORDERS, 2011, 26 : S137 - S137
[42] Long-Term Treatment with Extended-Release Carbidopa–Levodopa (IPX066) in Early and Advanced Parkinson’s Disease: A 9-Month Open-Label Extension Trial
Cheryl H. Waters
Paul Nausieda
Lyudmila Dzyak
Joerg Spiegel
Monika Rudzinska
Dee E. Silver
Elena S. Tsurkalenko
Sherron Kell
Ann Hsu
Sarita Khanna
Suneel Gupta
CNS Drugs, 2015, 29 : 341 - 350
[43] Open-label comparison of IPX066, a novel investigational carbidopa-levodopa (CD-LD) extended-release formulation, and controlled-release CD-LD (CR) in Parkinson's disease patients with motor fluctuation
Tetrud, J.
Liang, G.
Nausieda, P.
Hsu, A.
O'Connell, M.
Khanna, S.
Kell, S.
Ellenbogen, A.
Tanner, C. M.
Gupta, S.
MOVEMENT DISORDERS, 2014, 29 : S269 - S270
[44] Motor effects and safety of IPX203, an investigational extended-release formulation of carbidopa-levodopa, in advanced Parkinson's disease: A single-dose study
Stacy, M.
Biton, V.
Aldred, J.
Rubens, R.
Modi, N.
Mittur, A.
Khanna, S.
Gupta, S.
MOVEMENT DISORDERS, 2017, 32
[45] Double-Blind, Placebo-Controlled Fixed-Dose Trial of IPX066, a Novel Carbidopa-Levodopa (CD-LD) Extended-Release Formulation, in Early Parkinson's Disease (APEX-PD Trial)
Pahwa, Rajesh
Hauser, Robert
Jankovic, Joseph
Nausieda, Paul
Ellenbogen, Aaron
Hsu, Ann
Gupta, Sunell
NEUROLOGY, 2011, 77 (02) : 199 - 199
[46] Motor effects and safety of IPX203, an investigational extended-release formulation of carbidopa-levodopa, in advanced Parkinson's disease: A single-dose Phase 2 study
Stacy, Mark
Biton, Victor
Aldred, Jason
Ellenbogen, Aaron
Rubens, Robert
Modi, Nishit
Mittur, Aravind
Khanna, Sarita
Gupta, Suneel
NEUROLOGY, 2017, 89 (08) : E99 - E99

← 1 2 3 4 5 →